Objective
To determine whether the alternate glycemic markers, fructosamine (FA), glycated albumin (GA), and 1,5-anhydroglucitol (1,5AG), predict glycemic variability captured by continuous glucose monitoring (CGM) in obese youth with prediabetes and type 2 diabetes (T2D).
Study Design
Youth with BMI ≥85th%ile, 10-18 years, had collection of fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), FA, GA, and 1,5AG and 72 hours of CGM. Participants with HbA1c ≥5.7% were included. Relationships between glycemic markers and CGM variables were determined with Spearman correlation coefficients. Linear models were used to examine the association between alternate markers and CGM measures of glycemic variability – standard deviation (SD) and mean amplitude of glycemic excursions (MAGE) – after controlling for HbA1c.
Results
Total n=56; Median (25th%ile,75th%ile) age=14.3 yrs (12.5, 15.9), 32% male, 64% Hispanic, 20% black, 13% white, HbA1c=5.9% (5.8, 6.3), FA=211mmol/L (200, 226), GA=12% (11%, 12%), and 1,5AG=22mcg/ml (19,26). HbA1c correlated with average sensor glucose, AUC, SD, MAGE, and %time>140mg/dl. FA and GA correlated with average and peak sensor glucose, %time>140mg/dl and >200mg/dl, and MAGE. GA also correlated with SD and AUC180. 1,5AG correlated with peak glucose, AUC180, SD, and MAGE. After adjusting for HbA1c, all 3 markers independently predicted MAGE; FA and GA independently predicted SD.
Conclusions
Alternate glycemic markers predict glycemic variability as measured by CGM in youth with prediabetes and T2D. After adjusting for HbA1c, these alternate markers continued to predict components of glycemic variability detected by CGM.